Mike L. Altshuler
Research Subjects
Mike L. Altshuler has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Yuryevich Mironov
G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology
1 shared publication - Larisa P. Blinkova
I. Mechnikov Research Institute of Vaccines and Sera
1 shared publication
Latest Publications
- 1 June 2023
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 28 (2) , 98-109
Antibacterial microcins, class II: A review
In medicine, the issue of the use of effective antibacterial substances against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of microcins is their specific inhibitory activity against gram-negative microorganisms (Escherichia, Proteus, Salmonella, Pseudomonas, etc.). This review aimed to briefly summarize current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and scientific research. The review uses sources from the Russian Science Citation Index, Web of Science, Scopus, and PubMed databases.
- 1 June 2023
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 28 (2) , 98-109
Antibacterial microcins, class II: A review
In medicine, the issue of the use of effective antibacterial substances against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of microcins is their specific inhibitory activity against gram-negative microorganisms (Escherichia, Proteus, Salmonella, Pseudomonas, etc.). This review aimed to briefly summarize current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and scientific research. The review uses sources from the Russian Science Citation Index, Web of Science, Scopus, and PubMed databases.